SEOM clinical guideline for treatment of kidney cancer (2017).

Clin Transl Oncol · 2018 · PMC5785618 · PMID 29134564

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Another meta-analysis comparing effectiveness and adverse effects of different systemic treatments for non-ccRCCs described that single studies showed a trend towards favoring sunitinib in terms of OS and PFS (HR 1.41, 80% confidence interval) [ 44 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.